{"transactions":[{"id":874314,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T00:18:28.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on March 1, 2027, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":3.3,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001193125-26-086118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000119312526086118/ownership.xml","form_type":"4"}},{"id":1142862,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":130000,"derivative":{"exercise_price":1.92,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142861,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":23.97,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142860,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.92,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142859,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.09,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142858,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":135000,"derivative":{"exercise_price":1.92,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142857,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142856,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.92,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142855,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.47,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142854,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":24711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":24711,"derivative":{"exercise_price":1.92,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":24711},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142853,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":14.94,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":24711},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142852,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":66463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":66463,"derivative":{"exercise_price":1.92,"expiration_date":"2029-10-23","underlying":"Common Stock","underlying_shares":66463},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142851,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":66463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":11,"expiration_date":"2029-10-23","underlying":"Common Stock","underlying_shares":66463},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142850,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":139282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $1.92 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date.  Under the terms of the stock option award repricing, a repriced stock option award will revert to its original exercise price if exercised during the Retention Period. The \"Retention Period\", through which the Reporting Person must remain in service to the Issuer, commenced on the Repricing Date and ends upon the earliest of (i) the one-year anniversary of the Repricing Date, (ii) a Sale Event (as defined in the 2018 Plan and 2019 Plan, as applicable) and (iii) the termination of the Reporting Person's Service Relationship (as defined in the 2018 Plan and 2019 Plan, as applicable) due to the Reporting Person's death or disability."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":139282,"derivative":{"exercise_price":1.92,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":139282},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1142849,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T01:36:55.000Z","date":"2025-05-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":139282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 15, 2025, the Issuer's board of directors approved an option repricing (the \"Repricing\"), to be effective May 19, 2025 (the \"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, as amended (the \"2018 Plan\") or the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, as amended (the \"2019 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.23,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":139282},"source":{"system":"sec-edgar","filing":"0000950170-25-074818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025074818/ownership.xml","form_type":"4"}},{"id":1228921,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T21:52:42.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on March 3, 2026, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":145000,"derivative":{"exercise_price":1.67,"expiration_date":"2035-03-02","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0000950170-25-032314","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017025032314/ownership.xml","form_type":"4"}},{"id":1603297,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T22:36:47.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on March 1, 2025, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":130000,"derivative":{"exercise_price":23.97,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000950170-24-025004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000095017024025004/ownership.xml","form_type":"4"}},{"id":2043781,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-28T01:47:23.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on January 18, 2024, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":11.09,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-23-002907","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924323002907/doc4.xml","form_type":"4"}},{"id":2135613,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-19T01:50:41.000Z","date":"2022-10-18","kind":"purchase","acquired":true,"shares":50000,"price":0.9924,"value":49620.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.98 to $1.00, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0000899243-22-033782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924322033782/doc4.xml","form_type":"4"}},{"id":2432387,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T00:59:51.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on January 18, 2023, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":135000,"derivative":{"exercise_price":3.21,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0000899243-22-002517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924322002517/doc4.xml","form_type":"4"}},{"id":2820811,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-03T02:48:34.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over four years, with 25% vesting on March 1, 2022, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":11.47,"expiration_date":"2031-02-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-21-009237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924321009237/doc4.xml","form_type":"4"}},{"id":3233153,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-04T02:18:29.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":24711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over four years, with 25% vesting on March 1, 2021, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":24711,"derivative":{"exercise_price":14.94,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":24711},"source":{"system":"sec-edgar","filing":"0000899243-20-006864","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924320006864/doc4.xml","form_type":"4"}},{"id":3387238,"issuer":{"id":5418,"kind":"organization","name":"Cabaletta Bio, Inc."},"owners":[{"id":63962,"kind":"person","name":"Marda Anup","position":1,"cik":"0001790410","reported_name":"Marda Anup","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T00:39:41.000Z","date":"2019-10-24","kind":"grant","acquired":true,"shares":66463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over four years, with 25% vesting on October 24, 2020, and the remaining shares vesting in 12 equal quarterly installments thereafter."}],"balance_after":66463,"derivative":{"exercise_price":11,"expiration_date":"2029-10-23","underlying":"Common Stock","underlying_shares":66463},"source":{"system":"sec-edgar","filing":"0000899243-19-026018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759138/000089924319026018/doc4.xml","form_type":"4"}}]}